Affimed GmbH

We are a team of passionate, experienced individuals who work every day to improve the lives of patients. Led by an expert team of biotechnology and pharmaceutical professionals, we are united by one goal—to stop cancer from ever derailing patients’ lives. Inspired by the immense potential of the innate immune system, we are dedicated to unlocking profound possibilities—bringing new hope to those whose lives have been forever changed by the impact of cancer. With broad expertise in innate immunity, tumor biology, and antibody engineering, we are well situated to advance our unique and insightful approach for activating the innate immune system to fight cancer. Our novel and proprietary technology will allow us to develop and commercialize groundbreaking treatments across multiple tumor types.. Genentech will be responsible for clinical development and commercialization worldwide.